Blood Vessels in Meninges: Meningeal Vasculature in Health, Neuroimmunology, and Disease

1. Toichieva Zarina Jamaldinovna

2. Sayyed Mohammad Javvad

Jangalekar Monalisa Surendra

Takkalwar Parth Lingyya

Mohammad Faizan

(1. Professor, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic

2. Students, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic)

Abstract

The blood vessels of the meninges represent a remarkably diverse and functionally critical vascular network that sustains the central nervous system, maintains its immune surveillance, and facilitates waste clearance. Far from being passive conduits, meningeal blood vessels are specialized structures with distinct anatomical, histological, and molecular characteristics that vary across the dura mater, arachnoid mater, and pia mater, enabling them to fulfill layer-specific roles in brain homeostasis and defense. This review synthesizes current knowledge on the arterial supply, venous drainage, capillary networks, and lymphatic vessels of the cranial and spinal meninges, with particular emphasis on recent discoveries regarding fenestrated dural vasculature, the blood-meningeal barrier, leptomeningeal collateral circulation, and the neurovascular unit at the brain's borders. We examine the embryological development of meningeal vessels, their structural heterogeneity as revealed by electron microscopy and single-cell transcriptomics, and their dynamic regulation by neural, immune, and stromal cells. The review further explores the pathophysiology of meningeal vascular disorders including epidural and subdural hematoma, subarachnoid hemorrhage, dural arteriovenous fistula, and spinal cord ischemia, with attention to contemporary diagnostic and therapeutic approaches. Emerging concepts such as the skull-meninges-bone marrow vascular axis, meningeal lymphatic drainage, and the therapeutic targeting of collateral circulation in stroke are discussed. By integrating classical anatomical knowledge with cutting-edge discoveries from vascular biology, neuroimmunology, and clinical neuroscience, this article provides a comprehensive framework for understanding meningeal blood vessels as active participants in central nervous system biology and promising targets for neurological therapeutics.

1. Introduction

The human brain, despite comprising merely two percent of body weight, commands approximately twenty percent of the cardiac output and consumes disproportionate quantities of oxygen and glucose to sustain its intricate electrochemical activities. This extraordinary metabolic demand necessitates a vascular supply of exquisite complexity, yet the vessels that serve this purpose are not confined to the brain parenchyma alone. The meninges, the three membranous envelopes that cradle the brain and spinal cord, harbor their own elaborate vascular networks that are essential for the nourishment, protection, and immunological surveillance of the central nervous system. For centuries, the study of cerebral circulation focused predominantly on the intraparenchymal vessels—the arterioles, capillaries, and venules that weave through the cortical gray matter and white matter tracts—while the meningeal vasculature received comparatively scant attention, regarded perhaps as a mundane supporting cast to the more glamorous neural circulation. This historical neglect has been rectified in recent decades by a surge of research revealing that meningeal blood vessels are not mere ancillary structures but specialized, multifunctional interfaces that participate actively in neuroimmune communication, cerebrospinal fluid dynamics, and the pathogenesis of major neurological diseases.

The meninges consist of three principal layers: the dura mater, the arachnoid mater, and the pia mater, each possessing distinct vascular architectures that reflect their unique functional roles. The dura mater, the outermost and toughest layer, is richly vascularized by branches of the external carotid artery and contains fenestrated capillaries that permit free exchange of blood-borne molecules with the dural stroma, creating an immunological environment more akin to peripheral tissues than to the protected central nervous system parenchyma. The dural venous sinuses, endothelial-lined channels formed by dural reflections, serve as the major drainage routes for cerebral blood and cerebrospinal fluid, while also functioning as critical hubs for immune cell trafficking. The leptomeninges—the arachnoid and pia mater—contain vessels that are fundamentally different: non-fenestrated, tightly junctioned, and integrated into the blood-brain barrier system, yet capable of dramatic functional remodeling in response to ischemia, inflammation, and metabolic stress. The pial vessels, in particular, form the leptomeningeal collateral circulation, a network of anastomosing arterioles that can salvage ischemic brain tissue when primary arterial supply fails, representing one of the most important endogenous neuroprotective mechanisms in stroke.

The clinical significance of meningeal vasculature extends across virtually every domain of neurology and neurosurgery. Epidural hematoma, the accumulation of blood between the skull and dura mater, typically results from traumatic rupture of the middle meningeal artery and constitutes a neurosurgical emergency. Subdural hematoma, bleeding into the potential space between dura and arachnoid, reflects the vulnerability of bridging veins that traverse this interface. Subarachnoid hemorrhage, whether traumatic or aneurysmal, fills the cerebrospinal fluid compartments with blood, triggering vasospasm, hydrocephalus, and devastating neurological sequelae. Dural arteriovenous fistulas, abnormal shunts between meningeal arteries and venous sinuses, illustrate how pathological remodeling of dural vessels can produce hemorrhage, venous hypertension, and progressive neurological decline. Spinal cord infarction, often involving the anterior spinal artery or the artery of Adamkiewicz, demonstrates the catastrophic consequences of meningeal vascular insufficiency in the spinal canal. In each of these conditions, understanding the structural and functional properties of meningeal blood vessels is essential for rational diagnosis and effective intervention.

Beyond these classical vascular disorders, emerging research has illuminated novel roles for meningeal vessels in neuroimmunology and neurodegeneration. The discovery that dural blood vessels are fenestrated and support robust immune cell trafficking has challenged the traditional concept of the brain as an immunologically privileged organ. Meningeal lymphatic vessels, closely associated with dural venous sinuses and meningeal arteries, provide a drainage route for cerebrospinal fluid and brain-derived antigens, linking central nervous system immunity to peripheral lymph nodes. The skull-meninges vascular axis, comprising emissary veins and transosseous channels, enables direct communication between cranial bone marrow and the dura, creating a localized hematopoietic niche that supplies immune cells to the meninges independent of systemic circulation. These discoveries have transformed our understanding of how the brain maintains immune surveillance, clears metabolic waste, and responds to injury, with profound implications for conditions ranging from multiple sclerosis to Alzheimer's disease.

We begin with the embryological development and anatomical organization of meningeal vasculature, followed by detailed examination of arterial supply, venous drainage, capillary networks, and lymphatic vessels in each meningeal layer. We then explore the cellular and molecular architecture of the neurovascular unit at meningeal borders, the dynamic regulation of vascular function by neural and immune signals, and the mechanisms of vascular remodeling in response to physiological and pathological stimuli. The discussion extends to the pathophysiology, diagnosis, and management of major meningeal vascular disorders, and concludes with an evaluation of emerging therapeutic strategies targeting meningeal vasculature. Throughout, we emphasize the integration of classical anatomical knowledge with recent discoveries from advanced imaging, molecular genetics, and clinical trials to provide an up-to-date and clinically relevant perspective on this rapidly evolving field.

2. Materials and Methods

This review was conducted through a comprehensive and systematic search of the published literature, with particular emphasis on peer-reviewed articles, systematic reviews, and meta-analyses indexed in PubMed/MEDLINE, the Cochrane Library, and relevant neuroscience, neurology, neurosurgery, and vascular biology journals. The search strategy employed a combination of MeSH terms and free-text keywords including "meningeal blood vessels," "meningeal vasculature," "dural arteries," "dural venous sinuses," "leptomeningeal collateral circulation," "pial vessels," "blood-meningeal barrier," "meningeal lymphatic vessels," "neurovascular unit," "epidural hematoma," "subdural hematoma," "subarachnoid hemorrhage," "dural arteriovenous fistula," "spinal cord blood supply," "artery of Adamkiewicz," "middle meningeal artery," "meningeal immunity," "brain borders," "cerebrospinal fluid drainage," "stroke collateral circulation," and "meningeal neuroimmunology." The search was restricted to articles published in English, with priority given to publications from 2019 to 2026 to ensure currency, though seminal earlier works were included where essential for historical context or foundational concepts. Additional articles were identified through manual screening of reference lists from retrieved papers and from recent review articles in high-impact journals.

The selection criteria favored original research articles reporting mechanistic insights into meningeal vascular biology, clinical studies evaluating vascular imaging techniques or biomarkers, and randomized controlled trials of therapies targeting meningeal vascular pathways. Animal model studies were included where they provided critical mechanistic insights with clear translational relevance to human disease. Case reports and opinion pieces were generally excluded unless they provided unique clinical perspectives or reported novel observations of exceptional significance. Data extraction focused on vascular structures, cellular populations, molecular mechanisms, disease associations, and therapeutic outcomes. Where conflicting evidence existed, we prioritized findings from the most methodologically rigorous studies and acknowledged areas of uncertainty or ongoing debate. The synthesis of evidence was organized thematically to construct an integrated narrative highlighting the interconnectedness of meningeal vascular biology across physiological and pathological contexts.

3. Results

3.1 Embryological Development of Meningeal Vasculature

The development of blood vessels in the meninges is intimately linked to the formation of the meningeal layers themselves and to the establishment of the skull and vertebral column that enclose them. Understanding these developmental origins is essential for appreciating the regional heterogeneity of meningeal vascular structure and function, as well as the basis for certain congenital vascular anomalies. The central nervous system develops from the neuroectoderm, which folds to form the neural tube during the third and fourth weeks of gestation. As the neural tube closes, the surrounding mesenchyme condenses to form the primitive meninx, which subsequently differentiates into the three definitive meningeal layers and acquires its vascular supply from adjacent embryonic vessels.

Early experiments using quail-chick chimeras demonstrated that neural crest-derived cells, generated from the caudal forebrain and midbrain levels, contributed to the meninges associated with the forebrain, whereas mesoderm-derived cells gave rise to the meninges of the midbrain and hindbrain. In all areas, however, the endothelial cells of meningeal blood vessels were strictly of mesodermal origin, highlighting the diverse cellular sources that contribute to the mature meningeal vasculature. This fundamental principle—that meningeal vessels arise from mesodermal endothelial precursors regardless of the neural crest or mesodermal origin of the surrounding meningeal tissue—has significant implications for understanding regional differences in vascular biology and disease susceptibility. The forebrain meninges, predominantly neural crest-derived in their cellular composition, are vascularized by branches of the internal carotid and external carotid systems, while the midbrain and hindbrain meninges, primarily mesodermal in origin, receive blood from the vertebrobasilar system and meningeal branches of the occipital artery.

The middle meningeal artery, the largest and most clinically significant dural artery, has a particularly complex embryological origin that explains its numerous anatomical variations. It arises from the hyostapedial system, an embryonic vascular plexus associated with the first pharyngeal arch, and its development is intimately related to the formation of the middle ear structures. This developmental history explains why the middle meningeal artery can occasionally originate from aberrant locations including the internal carotid artery, the ophthalmic artery, or even the basilar artery, and why it maintains anastomotic connections with branches of the internal carotid system that can have profound clinical consequences during endovascular procedures. The intricate embryogenesis of the middle meningeal artery gives rise to a myriad of anatomical variations involving its origin, branching pattern, and connections with adjacent arterial systems, all of which must be understood by neuroradiologists and neurosurgeons to ensure safe therapeutic interventions.

The dural venous sinuses develop from the primitive venous plexuses that surround the neural tube and are molded by the growth of the skull and brain. The superior sagittal sinus, for instance, forms within the fold of dura mater that becomes the falx cerebri, while the transverse sinuses develop within the tentorium cerebelli. Unlike systemic veins, the dural sinuses lack a tunica media and tunica adventitia, possessing only an endothelial lining supported by dural connective tissue. This unique structure, while enabling the sinuses to accommodate large volumes of venous blood and cerebrospinal fluid, also renders them vulnerable to traumatic injury and thrombotic occlusion. The meningeal lymphatic vessels, rediscovered in 2015 after being overlooked for centuries, develop from lymphatic sacs that bud from the cardinal veins and migrate along the paths of meningeal arteries to establish a network aligned with the dural venous sinuses and cranial nerves.

3.2 Arterial Supply to the Cranial Meninges

The arterial supply to the cranial meninges is derived from multiple sources, reflecting the complex embryological development of the skull and its coverings. The external carotid artery, through its maxillary branch, gives rise to the anterior, middle, and posterior meningeal arteries that supply the majority of the dura mater. The internal carotid artery contributes the ophthalmic artery, which gives off meningeal branches to the anterior cranial fossa, while the vertebral artery provides the posterior meningeal artery that vascularizes the posterior fossa dura. This segmental arterial supply creates a rich anastomotic network across the dural surface, ensuring collateral perfusion that can be critical when individual vessels are compromised by trauma, surgery, or embolization.

The middle meningeal artery stands as the largest and most important of the meningeal arteries, typically arising from the internal maxillary artery in the infratemporal fossa and entering the cranial cavity through the foramen spinosum. Its clinical significance cannot be overstated: it supplies more than two-thirds of the cranial dura mater, including the dura of the convexity, the middle cranial fossa, and portions of the anterior and posterior fossae. After entering the skull, the middle meningeal artery courses briefly on the greater wing of the sphenoid bone before dividing into anterior and posterior divisions at the pterional region. The anterior division, also known as the frontal division, passes across the greater wing of the sphenoid bone and enters the sphenoparietal canal, giving off the medial or sphenoidal branch and the orbital branch before terminating in falcine arteries that supply the falx cerebri and contralateral branches that cross the midline to anastomose with the contralateral middle meningeal artery. The posterior division, or parietal division, courses posteriorly across the squamous part of the temporal bone, reaching the lower margin of the parietal bone and giving rise to the petrosquamosal branch and the parieto-occipital branch that participate in vascularizing the temporosquamous dura, the parieto-occipital convexity, and the transverse and sigmoid sinuses.

Before its bifurcation, the middle meningeal artery gives off several important branches. The petrosal branch courses on the petrous apex and supplies the dura of this region, including the gasserian ganglion and the superior part of the tympanic cavity via the superior tympanic artery. The cavernous branch supplies the lateral wall of the cavernous sinus and anastomoses with branches of the inferolateral trunk of the internal carotid artery. These branches are not merely anatomical curiosities; they represent potential pathways for the spread of infection, tumor, and embolic material between the middle ear, the cavernous sinus, and the intracranial compartment. The middle meningeal artery also partially supplies cranial nerves, including the trigeminal and facial nerves, through its petrosal branch, which gives branches to the gasserian ganglion and to the maxillary and mandibular divisions of the trigeminal nerve in their cavernous portion, as well as to the greater superficial petrosal nerve and the geniculate ganglion of the facial nerve.

The anterior meningeal artery, a branch of the ethmoidal arteries derived from the ophthalmic artery, supplies the dura of the anterior cranial fossa, the falx cerebri, and the anterior portion of the superior sagittal sinus. The posterior meningeal artery, arising from the vertebral artery or the occipital artery, supplies the dura of the posterior cranial fossa, the falx cerebelli, and the posterior portion of the superior sagittal sinus and tentorium. The accessory meningeal artery, a small and inconstant vessel, may arise from the internal maxillary artery and supply the dura of the middle cranial fossa and the trigeminal ganglion. The rich anastomotic network formed by these vessels ensures that the dura mater receives adequate perfusion even when individual arteries are ligated or occluded, a feature that has both physiological significance and therapeutic implications for endovascular procedures.

The spinal meninges receive their arterial supply from segmental arteries that accompany the spinal nerves. These segmental arteries give off meningeal branches that enter the vertebral canal through the intervertebral foramina and anastomose with branches of the anterior and posterior spinal arteries to form a network on the surface of the spinal cord. The arterial supply of the spinal dura is thus segmental and metameric, reflecting the segmented development of the vertebral column and spinal cord, in contrast to the more complex and less segmentally organized cranial dural vasculature.

3.3 Venous Drainage and the Dural Venous Sinuses

The venous drainage of the brain and meninges occurs through a unique system of endothelial-lined channels, the dural venous sinuses, which differ fundamentally from conventional veins in their structure and function. Unlike systemic veins, which possess a tunica media containing smooth muscle and a tunica adventitia of connective tissue, the dural venous sinuses are formed by the separation of the periosteal and meningeal layers of the dura mater and are lined by endothelium supported only by the dense collagenous tissue of the dural reflections. They contain no valves, allowing blood to flow in either direction depending on pressure gradients, and their walls are capable of considerable distension to accommodate fluctuations in intracranial pressure. These structural features make the dural sinuses ideally suited for their dual role in draining cerebral venous blood and absorbing cerebrospinal fluid, while also serving as critical interfaces for immune cell trafficking between the central nervous system and the periphery.

The superior sagittal sinus, the largest of the dural venous sinuses, runs along the attached margin of the falx cerebri from the foramen caecum anteriorly to the confluence of sinuses posteriorly. It receives blood from the superior cerebral veins, which drain the superolateral and medial surfaces of the cerebral hemispheres, and from diploic and meningeal veins. Along its course, the superior sagittal sinus contains arachnoid granulations, cauliflower-like protrusions of arachnoid mater that project through the dural wall into the sinus lumen and serve as the primary sites of cerebrospinal fluid absorption into the venous bloodstream. The inferior sagittal sinus, smaller than its superior counterpart, runs along the free lower edge of the falx cerebri and joins the straight sinus at the tentorial apex. The straight sinus, formed by the union of the inferior sagittal sinus and the great cerebral vein of Galen, runs along the line of attachment of the falx cerebri to the tentorium cerebelli and drains into the confluence of sinuses. The transverse sinuses, extending laterally from the confluence within the tentorial attachments, course along the occipital bone and become the sigmoid sinuses, which curve downward to exit the skull through the jugular foramen as the internal jugular veins.

The cavernous sinuses, situated on either side of the sella turcica, are unique among the dural venous sinuses in their complex anatomical relationships. Each cavernous sinus contains the internal carotid artery with its sympathetic plexus, and the abducens nerve, while the oculomotor, trochlear, ophthalmic, and maxillary nerves pass through its lateral wall. The cavernous sinuses are connected to each other by the anterior and posterior intercavernous sinuses, which form a circular sinus around the pituitary gland, and they drain anteriorly into the superior and inferior ophthalmic veins and posteriorly into the superior and inferior petrosal sinuses. Their connections with the facial veins through the ophthalmic veins create a potential pathway for the spread of infection from the face to the intracranial compartment, a route famously known as the dangerous triangle of the face.

The petrosal sinuses, superior and inferior, run along the petrous part of the temporal bone and connect the cavernous sinus to the sigmoid sinus. The occipital sinus, the smallest of the dural venous sinuses, lies within the falx cerebelli and drains the cerebellar region. The sphenoparietal sinus courses along the lesser wing of the sphenoid bone and drains into the cavernous sinus. These sinuses are not merely passive drainage channels; they are active participants in intracranial pressure regulation, cerebrospinal fluid dynamics, and immune surveillance. The dural sinuses are lined by endothelial cells that express high levels of adhesion molecules, including vascular cell adhesion molecule-1 and intercellular adhesion molecule-1, which facilitate the binding and extravasation of immune cells. The perisinusal dural stroma contains abundant antigen-presenting cells, including macrophages and dendritic cells, that capture cerebrospinal fluid-borne antigens and present them to circulating T cells, creating a unique immunological niche at the brain's venous outflow.

The meningeal lymphatic vessels, rediscovered in 2015 after being overlooked for over a century, are intimately associated with the dural venous sinuses and meningeal arteries. These lymphatic vessels run alongside the dural sinuses and major meningeal arteries, draining cerebrospinal fluid and brain-derived antigens to the deep cervical lymph nodes. They represent a critical alternative drainage pathway that complements the classical absorption of cerebrospinal fluid through arachnoid granulations into the dural venous sinuses. The meningeal lymphatics are particularly dense in the basal portions of the skull, where they cross the cribriform plate to reach the nasal mucosa, and along the transverse sinuses, where they facilitate the clearance of macromolecular waste from the central nervous system. The functional significance of these vessels has been highlighted by studies demonstrating that their impairment accelerates the accumulation of amyloid-beta in Alzheimer's disease models and exacerbates neuroinflammation in multiple sclerosis, establishing them as potential therapeutic targets for neurodegenerative and neuroinflammatory disorders.

3.4 Capillary Networks and the Blood-Meningeal Barrier

The capillary networks of the meninges exhibit striking heterogeneity across the different meningeal layers, reflecting their distinct functional roles in central nervous system homeostasis and defense. The dura mater contains fenestrated capillaries and postcapillary venules that are freely permeable to blood-borne molecules, including proteins as large as 43 kilodaltons, creating a microenvironment that resembles peripheral tissues rather than the immunologically privileged central nervous system parenchyma. This fenestrated vasculature is essential for the dura's role as an immunological sentinel, allowing circulating immune cells, antibodies, and complement components to access the dural stroma where they can interact with resident antigen-presenting cells and participate in immune surveillance. The permeability of dural vessels is dynamically regulated; it increases further upon trigeminal nerve stimulation or histamine release, suggesting active neuroimmune modulation of vascular function. The dural capillary bed is particularly dense in the deeper layers of the dura, just above the dural border cell layer, where it forms an extensive network that supports the metabolic demands of dural fibroblasts, immune cells, and nerve fibers.

In contrast to the dura, the leptomeningeal vessels—those within the arachnoid mater, subarachnoid space, and pia mater—are non-fenestrated and possess tight junctions between endothelial cells that restrict paracellular permeability. These vessels are thus integrated into the blood-brain barrier system, although they are not surrounded by astrocytic endfeet like the intraparenchymal capillaries. The pial vessels, which run on the surface of the brain within the pial sheath, are characterized by endothelial tight junctions composed of claudin-5, occludin, and junctional adhesion molecules that confer barrier properties similar to those of cerebral capillaries. The transendothelial electrical resistance of pial microvessels is approximately 2000 ohm-square centimeters, compared to 1 to 3 ohm-square centimeters in mesenteric capillaries, reflecting the exceptional tightness of these junctions. This barrier function is critical for preventing the unregulated entry of blood-borne substances into the cerebrospinal fluid and for maintaining the ionic and molecular composition of the fluid that bathes the brain surface.

The arachnoid mater itself is avascular, receiving its nutrition by diffusion from the dural vessels and the cerebrospinal fluid. However, the subarachnoid space contains numerous vessels that course through the cerebrospinal fluid en route to the brain parenchyma. These vessels are encased in pial sheaths that create the perivascular or Virchow-Robin spaces, which serve as conduits for fluid and cellular exchange between the subarachnoid space and the brain interstitium. The pial sheath is continuous with the pia mater and contains collagen fibers, fibroblasts, and occasional macrophages, forming a distinct compartment that is separated from the cerebrospinal fluid by the pial cell layer. The vessels within the subarachnoid space are subject to the pulsatile forces of cerebral blood flow and cerebrospinal fluid pressure, which drive the glymphatic circulation—the brain-wide clearance system that removes metabolic waste and distributes nutrients.

The blood-meningeal barrier, while less restrictive than the blood-brain barrier proper, plays a crucial role in regulating the exchange of cells and molecules between the blood and the cerebrospinal fluid compartments. The dural vessels, with their fenestrated endothelium, allow immune cells to extravasate and survey the dural stroma, while the arachnoid barrier, sealed by tight junctions of claudin-11, prevents free diffusion of these cells and molecules into the subarachnoid space. However, recent discoveries have revealed that this barrier is not absolute. Arachnoid cuff exit points, specialized structures where bridging veins penetrate the arachnoid barrier to reach the dural venous sinuses, create discontinuities that permit controlled exchange between the subarachnoid and dural compartments. These structures, closely associated with meningeal lymphatic vessels, may facilitate the clearance of large molecular waste from the subarachnoid space into the dura and ultimately to the lymphatic drainage system. The molecular mechanisms governing this selective permeability remain incompletely understood but likely involve laminin-mediated cellular guidance and dynamic regulation of tight junction composition.

3.5 The Neurovascular Unit at Meningeal Borders

The neurovascular unit, a concept formalized in 2001 by the Stroke Progress Review Group of the National Institute of Neurological Disorders and Stroke, refers to the integrated cellular network comprising vascular cells, glial cells, and neurons that coordinate to maintain brain homeostasis and respond to injury. While the neurovascular unit has been extensively studied in the brain parenchyma, its composition and function at the meningeal borders exhibit unique features that are increasingly recognized as critical for central nervous system health and disease. The meningeal neurovascular unit includes endothelial cells, pericytes, vascular smooth muscle cells, basement membrane components, astrocytic endfeet, microglia, and neurons, all of which engage in bidirectional signaling that regulates vascular tone, barrier permeability, immune surveillance, and metabolic exchange.

Pericytes are fundamental components of the meningeal neurovascular unit, positioned between endothelial cells and the basement membrane along capillaries, pre-capillary arterioles, and post-capillary venules. The central nervous system has the highest density of pericytes compared with other tissues, with approximately 70 to 80 percent of microvessels covered by these cells. Meningeal pericytes, like their intraparenchymal counterparts, express platelet-derived growth factor receptor-beta, alpha-smooth muscle actin, and the transmembrane chondroitin sulfate proteoglycan NG2, enabling them to regulate capillary blood flow, maintain blood-brain barrier stability, and participate in immune responses. However, meningeal pericytes exhibit regional heterogeneity: precapillary pericytes wrap around vessels with circumferential processes and express high levels of contractile proteins, enabling bidirectional regulation of blood flow; midcapillary pericytes are elongated spindle-shaped cells that extend processes parallel to microvessels and have a major role in barrier maintenance; while postcapillary pericytes have a stellate morphology and participate in immune cell trafficking and phagocytosis.

The basement membrane of the meningeal neurovascular unit is a specialized extracellular matrix that surrounds cerebral microvessels at the interface between endothelial cells, contractile cells, and astrocytic endfeet. It is composed of laminin, collagen IV, nidogen, and perlecan, all of which are synthesized by pericytes, endothelial cells, and astrocytes. This basement membrane is not merely a passive scaffold but an active signaling platform that regulates cell adhesion, migration, and differentiation. The production of extracellular matrix proteins by pericytes is stimulated by transforming growth factor-beta, which also upregulates cadherin-2 and stabilizes tight junctions in cerebral endothelial cells. Pericytes also produce matrix metalloproteinase-2 and matrix metalloproteinase-9, which enhance basement membrane degradation during angiogenesis, and tissue inhibitor of metalloproteinase-3, which facilitates vessel maturation and stabilization. The dynamic balance between synthesis and degradation of basement membrane components is critical for the structural integrity and functional plasticity of meningeal vessels.

Astrocytes, the most abundant glial cells in the central nervous system, make contact with both pericytes and endothelial cells at the meningeal vascular wall through their endfeet processes. Astrocytes release laminin, which binds to integrin alpha-2 on pericytes and maintains them in a barrier-stabilizing phenotype, preventing their transition to a contractile state that could compromise vascular integrity. Astrocytes also regulate the polarization of aquaporin-4 water channels to the perivascular astrocytic endfoot membrane, a process essential for glymphatic fluid exchange and waste clearance. In the meninges, astrocytic endfeet form the glia limitans, a barrier of surface-associated astrocytes that represents the final cellular boundary before the brain parenchyma. The glia limitans is continuous with the pia mater basement membrane, creating a seamless transition between meningeal and parenchymal barrier systems. During inflammation, the integrity of the glia limitans can be compromised by reactive oxygen species, tumor necrosis factor-alpha, and interferon-gamma produced by meningeal immune cells, allowing inflammatory mediators and immune cells to penetrate into the brain parenchyma.

Vascular smooth muscle cells in the meningeal neurovascular unit are found primarily in arterioles and arteries, where they regulate vascular tone and cerebral blood flow. These cells are responsive to neurotransmitters including noradrenaline, acetylcholine, and serotonin, as well as to neuropeptides such as calcitonin gene-related peptide, substance P, and vasoactive intestinal peptide released from perivascular nerve fibers. The dural vessels, in particular, are richly innervated by sensory and autonomic nerve fibers that can induce vasoconstriction or vasodilation in response to physiological and pathological stimuli. Vasoconstriction of dural vessels can be caused by increased luminal pressure, noradrenaline, and neuropeptide Y, while vasodilation is induced by electrical stimulation, calcitonin gene-related peptide, substance P, acetylcholine, histamine, and serotonin. This neurovascular coupling is essential for the regulation of cerebral blood flow but also contributes to the pathophysiology of migraine, where activation of meningeal nociceptors and release of neuropeptides produces painful neurogenic inflammation.

3.6 Leptomeningeal Collateral Circulation

The leptomeningeal collateral circulation represents one of the most important endogenous neuroprotective mechanisms in the human brain, providing an alternative route for blood flow when primary arterial supply is compromised by occlusion or stenosis. This network of small arteriole-to-arteriole anastomoses connects the terminal branches of the major cerebral arteries—the anterior cerebral artery, middle cerebral artery, and posterior cerebral artery—on the surface of the brain within the pia mater. Under normal physiological conditions, these collateral vessels are small, with diameters of approximately 300 micrometers, and there is no pressure gradient across their walls, resulting in minimal net blood flow. However, following arterial occlusion, the pressure drop in the downstream territory creates a gradient that drives retrograde flow through the collaterals, perfusing the ischemic penumbra and preventing or delaying neuronal death.

The anatomical architecture of leptomeningeal collaterals has been studied since the pioneering work of Otto Heubner in 1874, who first demonstrated their presence by injecting the cerebral arteries and observing filling of the entire arterial tree even when the circle of Willis was blocked. Inter-territorial anastomoses exist between all three major cerebral arterial systems: between the anterior cerebral artery and middle cerebral artery, the posterior cerebral artery and middle cerebral artery, the anterior cerebral artery and posterior cerebral artery, and even between the right and left anterior cerebral arteries across the midline. Intra-territorial anastomoses connect adjacent arterial branches within the same arterial territory, providing additional redundancy within each vascular distribution. There is considerable anatomical variation in collateral circulation between individuals, and this variation is a major determinant of stroke outcome. Patients with robust collateral networks can tolerate even complete internal carotid artery occlusion without infarct development, while those with poor collaterals suffer extensive damage from seemingly minor occlusions.

The functional recruitment of leptomeningeal collaterals following arterial occlusion is remarkably rapid. In animal models, maximal dilation of these vessels occurs within 12 seconds after internal carotid artery occlusion, a response mediated by the release of vasodilatory factors including nitric oxide, adenosine, and prostaglandins from the endothelium and surrounding cells. The collaterals then undergo structural remodeling over days to weeks, with smooth muscle cells losing their contractile phenotype and adopting a proliferative synthetic state that allows vessel wall thickening and lumen enlargement. This remodeling process, termed arteriogenesis, is driven by hemodynamic forces, inflammatory signals, and growth factors including vascular endothelial growth factor, platelet-derived growth factor, and transforming growth factor-beta. However, the rate of natural collateral remodeling is often too slow to salvage substantial penumbra in acute stroke, highlighting the need for therapeutic strategies to accelerate this process.

The clinical importance of leptomeningeal collateral circulation in acute ischemic stroke has been firmly established by numerous studies demonstrating that robust collateral flow is associated with smaller infarct volumes, better response to reperfusion therapies, and improved functional outcomes. Collateral status is now recognized as a key factor in patient selection for endovascular thrombectomy, with good collaterals predicting favorable outcomes even when reperfusion is delayed. Conversely, poor collateral status is associated with worse outcomes, extensive infarct damage, and higher rates of hemorrhagic transformation after reperfusion. Multiple factors influence collateral status, including age, hypertension, diabetes, and genetic variation. Hypertension is significantly associated with poor collateral status, likely due to impaired collateral growth and endothelial dysfunction. Diabetes and elevated admission glucose levels are also associated with unfavorable collaterals, possibly through impaired nitric oxide availability and endothelium-dependent vasodilation. These findings suggest that management of cardiovascular risk factors may contribute to better collateral status and improved stroke outcomes.

Therapeutic strategies aimed at enhancing leptomeningeal collateral flow are an active area of research. Remote ischemic postconditioning, whereby brief periods of ischemia are induced in a distal limb immediately after stroke onset, has been shown to enhance collateralization in animal studies and has demonstrated safety and feasibility in clinical trials. Sphenopalatine ganglion stimulation, which increases parasympathetic activity and cerebral blood flow, has shown potential benefit in patients with acute ischemic stroke with cortical involvement. Statins, widely prescribed for cardiovascular prevention, may enhance collateralization through increased nitric oxide synthesis, and prestroke statin use has been associated with smaller infarct volumes and increased collateral flow in some studies. However, acute-phase statin administration has not yielded positive results in clinical trials, suggesting that collateral enhancement may require chronic rather than acute intervention. The development of more robust methods for quantifying collateral flow in humans, including dynamic regional scoring of pial collateral flow and the multi-measure cerebral collateral cascade, promises to improve patient stratification and guide therapeutic decision-making in acute stroke.

3.7 Meningeal Vasculature in Neuroimmunology

The blood vessels of the meninges have emerged as critical players in central nervous system immunology, challenging the long-standing concept of the brain as an immunologically privileged organ isolated from peripheral immune surveillance. The dural vasculature, with its fenestrated capillaries and high expression of leukocyte adhesion molecules, creates a microenvironment that is uniquely permissive for immune cell trafficking, antigen presentation, and immune activation. This immunological openness is not a vulnerability but an evolved feature that enables the central nervous system to monitor and respond to peripheral threats while maintaining the integrity of the neural parenchyma through the more restrictive blood-brain barrier.

The dural venous sinuses, in particular, function as immunological hubs where circulating T cells constantly access central nervous system-enriched antigens with the help of local antigen-presenting cells. The sinus endothelium expresses high levels of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1, which enable binding to integrins expressed on leukocytes, including lymphocyte function-associated antigen-1 and very late antigen-4. After adhesion and arrest, T cells extravasate through the dural sinuses and accumulate in the perisinusal stroma, where they interact with dendritic cells and macrophages that have captured cerebrospinal fluid-borne antigens. These antigen-presenting cells are identified by their high expression of major histocompatibility complex class II and are strategically positioned to sample antigens draining from the subarachnoid space. The T cells that recognize cognate antigens display tissue-resident phenotypes and effector functions, enabling efficient immune surveillance of the central nervous system in homeostasis. This perisinusal localization of antigen-presenting cells and accumulation of brain-enriched proteins have been observed in human postmortem samples, suggesting the presence of shared mechanisms underlying immune surveillance at the dural sinuses across species.

The leptomeningeal vasculature, while less permissive than the dural vasculature, also enables immune cell trafficking under inflammatory conditions. During neuroinflammation, leptomeningeal vessels upregulate vascular cell adhesion molecule-1 and intercellular adhesion molecule-1, enabling very late antigen-4 and lymphocyte function-associated antigen-1 engagement and promoting the extravasation of activated T cells and monocytes. Leptomeningeal macrophages produce chemokines including CCL5 and CXCL9-11 that promote the chemotactic recruitment of these cells into the cerebrospinal fluid and subarachnoid space. However, such trafficking through the leptomeningeal vasculature is largely limited to inflammatory conditions or autoreactive central nervous system T cells, as these vessels phenocopy the brain vasculature to restrict access under homeostatic conditions. The relative contributions of dural versus leptomeningeal routes for immune cell entry into the central nervous system during different disease states remain incompletely understood and represent an active area of investigation.

The meningeal lymphatic vessels, closely associated with dural blood vessels, provide a drainage route for cerebrospinal fluid and central nervous system-derived antigens to the deep cervical lymph nodes, enabling the activation of peripheral immune responses against brain-derived antigens. This pathway is essential for maintaining central nervous system immune tolerance and for coordinating adaptive immune responses during infection, trauma, and neurodegeneration. The lymphatic vessels are also involved in the clearance of macromolecular waste from the brain, including amyloid-beta and tau proteins, and their dysfunction has been implicated in the pathogenesis of Alzheimer's disease. The meningeal lymphatics are dynamically regulated by vascular endothelial growth factor-C signaling, and their growth and function can be modulated by immune cells, stromal cells, and neuronal activity. Understanding the crosstalk between meningeal blood vessels, lymphatic vessels, and immune cells is essential for developing new therapeutic strategies for neuroinflammatory and neurodegenerative diseases.

The skull-meninges vascular axis represents a novel paradigm in neuroimmunology that links the cranial bone marrow to the dural vasculature through emissary veins and transosseous channels. These small vessels, measuring approximately 80 to 100 micrometers in length and 20 micrometers in diameter, connect the dural venous system with the diploic venous system and the bone marrow cavity. Many immune cells in the dura come from skull and spine bone marrow rather than blood, traveling along blood vessel surfaces and through these tiny bone channels to reach the meninges. Following brain injury or during neuroinflammation, the bone marrow in the calvaria and vertebrae provides monocytes and neutrophils to both the meninges and brain parenchyma, creating a localized hematopoietic response that is independent of systemic circulation. This skull-meninges-bone marrow axis enables rapid and targeted immune responses to central nervous system insults and may explain why some therapeutic interventions targeting systemic immune cells have limited efficacy in brain diseases.

3.8 Pathophysiology of Meningeal Vascular Disorders

Epidural hematoma, the accumulation of blood between the inner table of the skull and the dura mater, represents a classic meningeal vascular emergency with distinctive pathophysiological features. The vast majority of epidural hematomas are arterial in origin, resulting from traumatic rupture of the middle meningeal artery, typically after a skull fracture in the temporal region. The middle meningeal artery's intimate relationship with the inner skull surface, running in a bony groove that renders it vulnerable to displacement and laceration by fracture fragments, explains its predilection for injury. The resulting arterial bleeding dissects the dura away from the skull, creating a lens-shaped collection on computed tomography that exerts mass effect on the underlying brain. The classical clinical presentation of epidural hematoma includes a lucid interval between the initial trauma and subsequent neurological deterioration, though this pattern is not invariable. Venous epidural hematomas, less common than their arterial counterparts, typically occur in pediatric patients after skull fractures that tear diploic or meningeal veins. The treatment of epidural hematoma is surgical evacuation, often via burr hole or craniotomy, with excellent outcomes when performed promptly.

Subdural hematoma, bleeding into the potential space between the dura mater and arachnoid mater, reflects the anatomical vulnerability of bridging veins that traverse this space to connect the cerebral cortex with dural venous sinuses. These veins are particularly susceptible to shear forces generated when the brain moves relative to the skull during acceleration-deceleration injury, as occurs in falls, motor vehicle accidents, and abusive head trauma. In elderly individuals, cerebral atrophy stretches bridging veins across an enlarged subdural space, increasing their vulnerability to even minor trauma. The low-pressure venous bleeding from torn bridging veins dissects the arachnoid away from the dura, creating a crescent-shaped collection that spreads over the cerebral convexity. Acute subdural hematoma carries a poor prognosis due to the associated underlying brain injury, while chronic subdural hematoma develops through a more complex process involving initial bleeding, neovascularization from the dural membrane, and repeated microhemorrhages from fragile new vessels. The coagulation and fibrinolysis systems are both excessively activated in chronic subdural hematoma, resulting in defective clot formation and recurrent hemorrhage that drives hematoma expansion. Treatment options range from observation for small asymptomatic collections to burr hole drainage or craniotomy for larger or symptomatic hematomas, with middle meningeal artery embolization emerging as a promising adjunct to reduce recurrence rates.

Subarachnoid hemorrhage, defined as bleeding into the subarachnoid space between the arachnoid and pia mater, is most commonly caused by rupture of a saccular cerebral aneurysm at the base of the brain. These aneurysms develop at bifurcations of the circle of Willis arteries, where hemodynamic stress and wall weakness combine to produce pouch-like protrusions of the vessel wall. When an aneurysm ruptures, blood under arterial pressure fills the subarachnoid space, mixing with cerebrospinal fluid and creating a characteristic pattern of diffuse bleeding visible on computed tomography. The clinical hallmark of aneurysmal subarachnoid hemorrhage is the thunderclap headache, described by patients as the worst headache of their life, often accompanied by nausea, vomiting, photophobia, and nuchal rigidity. The pathophysiology extends beyond the initial hemorrhage to include delayed cerebral ischemia from vasospasm, hydrocephalus from impaired cerebrospinal fluid circulation, and systemic complications including hyponatremia and cardiac dysfunction. Vasospasm, occurring 3 to 14 days after hemorrhage, results from the inflammatory and spasmogenic effects of blood breakdown products on arterial smooth muscle and is a major cause of morbidity and mortality. The mainstay of prevention is oral nimodipine, a dihydropyridine calcium channel blocker that reduces delayed cerebral ischemia and improves outcomes, though its mechanism may involve neuroprotective effects beyond simple vasodilation. Endovascular coiling or surgical clipping of the ruptured aneurysm prevents rebleeding, while advanced intensive care management addresses vasospasm, hydrocephalus, and systemic complications.

Dural arteriovenous fistula is a pathological shunt between dural arteries and dural venous sinuses or cortical veins, representing approximately 10 to 15 percent of all intracranial vascular malformations. These lesions are typically acquired rather than congenital, arising from progressive stenosis or occlusion of a dural venous sinus that leads to venous hypertension and the opening or development of arteriovenous shunts within the dural wall. The correlation between dural arteriovenous fistulas and hereditary thrombotic diseases, including factor V Leiden and protein C and S deficiencies, supports the hypothesis that venous thrombosis is a key initiating event. As venous sinus pressure increases, meningeal arteries develop fistulous connections with the sinus or cortical veins, either through enlargement of preexisting physiological shunts or de novo angiogenesis. The resulting high-flow shunt produces venous hypertension that can cause retrograde cortical venous drainage, intracerebral hemorrhage, venous infarction, and progressive neurological deficits. The clinical presentation varies widely depending on the location and hemodynamics of the fistula, ranging from pulsatile tinnitus and headache in benign cases to seizures, focal neurological deficits, and hemorrhage in aggressive cases. The Borden and Cognard classification systems stratify risk based on the pattern of venous drainage, with cortical venous drainage being the most important predictor of aggressive behavior. Treatment options include endovascular embolization, typically via the middle meningeal artery using liquid embolic agents or particles, surgical disconnection, and stereotactic radiosurgery, with multimodal approaches often required for complex lesions.

Spinal cord vascular disorders, while less common than their intracranial counterparts, demonstrate the critical importance of meningeal vasculature in spinal cord homeostasis. The spinal cord receives its blood supply from three longitudinal arteries: the anterior spinal artery, formed from branches of the vertebral arteries, which supplies the anterior two-thirds of the spinal cord; and the paired posterior spinal arteries, which supply the posterior one-third. These longitudinal arteries are reinforced by segmental radicular arteries that enter the spinal canal with the spinal nerves. The largest and most important of these is the artery of Adamkiewicz, also known as the great anterior radiculomedullary artery, which typically arises from the left side of the aorta between T9 and T12 and provides the primary blood supply to the lower two-thirds of the spinal cord. Injury to this artery during thoracoabdominal aortic surgery can cause anterior spinal artery syndrome, characterized by paraplegia, loss of pain and temperature sensation below the lesion level, and preserved proprioception and vibratory sensation, reflecting the differential vascularization of the anterior and posterior spinal cord. Spinal epidural and subdural hematomas, though rare, produce neurological injury through extrinsic compression of the spinal cord and nerve roots, with venous origin being most common due to the valveless epidural venous plexus that permits retrograde flow and congestion.

3.9 Therapeutic Targeting of Meningeal Vasculature

The evolving understanding of meningeal vascular biology has opened numerous avenues for therapeutic intervention across neurological diseases. In acute ischemic stroke, the leptomeningeal collateral circulation represents a prime therapeutic target, as augmenting collateral flow can extend the time window for reperfusion therapies and improve outcomes even when primary recanalization is unsuccessful. Strategies under investigation include remote ischemic conditioning, pharmacological enhancement of collateral tone using nitric oxide donors and phosphodiesterase inhibitors, and mechanical devices that divert blood flow to the cerebral circulation. The recognition that collateral status is a major determinant of stroke outcome has also influenced patient selection for endovascular thrombectomy, with advanced imaging techniques including computed tomography perfusion and multiphase computed tomographic angiography now used to assess collateral flow in real time.

Middle meningeal artery embolization has emerged as a minimally invasive treatment for chronic subdural hematoma, leveraging the understanding that the dural membrane surrounding these hematomas receives its blood supply from the middle meningeal artery and that interrupting this supply can prevent recurrent bleeding and promote hematoma resolution. Transarterial embolization using polyvinyl alcohol particles, coils, or liquid embolic agents such as Onyx has demonstrated high success rates with low morbidity, offering an alternative to surgical drainage in elderly patients with significant comorbidities. The middle meningeal artery is also the primary route for endovascular treatment of dural arteriovenous fistulas, with superselective catheterization and embolization of the arterial feeders achieving occlusion rates comparable to surgical disconnection with reduced invasiveness. However, the presence of dangerous anastomoses between the middle meningeal artery and the ophthalmic artery, including the meningolacrimal artery and the recurrent meningeal artery, requires meticulous angiographic evaluation to prevent inadvertent embolization of the retinal circulation and visual loss.

The meningeal lymphatic system has emerged as a novel therapeutic target for neurodegenerative diseases, particularly Alzheimer's disease. Strategies to enhance lymphatic drainage include vascular endothelial growth factor-C therapy to stimulate lymphangiogenesis, cervical deep lymphaticovenous anastomosis to improve outflow, and non-invasive mechanical stimulation of cervical lymphatics to enhance cerebrospinal fluid flow. Preclinical studies have demonstrated that improving meningeal lymphatic function enhances the clearance of amyloid-beta and reduces neuroinflammation in mouse models of Alzheimer's disease, suggesting that these approaches may have disease-modifying potential in humans. The combination of anti-amyloid immunotherapy with lymphatic enhancement is particularly promising, as improved drainage could facilitate the clearance of antibody-bound amyloid complexes from the brain.

Targeting the blood-meningeal barrier is another emerging therapeutic strategy, with potential applications in both enhancing drug delivery to the central nervous system and restricting immune cell entry in autoimmune diseases. The fenestrated dural vasculature offers a more accessible route for drug delivery than the tightly sealed blood-brain barrier, and understanding the molecular mechanisms that regulate dural vessel permeability could enable selective opening of this barrier for therapeutic purposes. Conversely, in multiple sclerosis and other neuroinflammatory diseases, strategies to strengthen the arachnoid barrier and prevent immune cell trafficking from the dura to the leptomeninges and parenchyma could ameliorate disease progression. The recognition that the leptomeninges, rather than the dura, are the primary site of autoimmune inflammation in multiple sclerosis suggests that compartment-specific therapies targeting leptomeningeal vessels may be more effective than systemic immunosuppression.

4. Discussion

The field of meningeal vascular biology has undergone a revolutionary transformation, evolving from a discipline focused on gross anatomical description to a vibrant area of research at the intersection of vascular biology, neuroimmunology, and clinical neuroscience. The evidence synthesized in this review establishes the blood vessels of the meninges as far more than passive conduits for blood; they are dynamic, multifunctional interfaces that actively participate in central nervous system homeostasis, immune surveillance, waste clearance, and response to injury. The molecular and cellular complexity of meningeal vasculature, as revealed by electron microscopy, single-cell transcriptomics, and advanced imaging, rivals that of many other organ systems, and the structural specializations discovered in recent years—including fenestrated dural capillaries, arachnoid cuff exit points, and the skull-meninges-bone marrow vascular axis—have fundamentally reshaped our understanding of how the brain interacts with the rest of the body.

Several themes emerge from this synthesis that have important implications for both research and clinical practice. First, the heterogeneity of meningeal blood vessels across the different meningeal layers reflects an evolved functional specialization that balances the need for immune surveillance with the need for neural protection. The dura mater, with its fenestrated capillaries and permissive immune environment, serves as a peripheral tissue-like interface that monitors the blood for signs of central nervous system infection or damage. The arachnoid mater, avascular and sealed by tight junctions, creates a barrier that prevents the unregulated entry of blood-borne substances into the cerebrospinal fluid. The pia mater, with its tightly junctioned vessels integrated into the blood-brain barrier system, allows controlled exchange between blood and brain while maintaining the ionic and molecular stability essential for neural function. This layered architecture, each with its distinct vascular properties, represents an elegant solution to the challenge of protecting the brain while keeping it informed about peripheral immune status.

Second, the leptomeningeal collateral circulation exemplifies the remarkable functional plasticity of meningeal blood vessels and their capacity for neuroprotection. The ability of pial arterioles to rapidly dilate and redirect blood flow in response to arterial occlusion is one of the most important endogenous defense mechanisms against ischemic stroke, yet this capacity varies enormously between individuals and declines with age and vascular risk factors. Understanding the molecular mechanisms that govern collateral tone, remodeling, and maturation is essential for developing therapies that can enhance this natural protective system. The recognition that collateral status is a major determinant of stroke outcome has already influenced clinical practice, with collateral assessment now integrated into patient selection algorithms for endovascular thrombectomy. Future advances in collateral enhancement, whether pharmacological, mechanical, or cell-based, could extend the therapeutic window for stroke intervention and improve outcomes for the substantial proportion of patients who remain disabled despite successful recanalization.

Third, the integration of meningeal blood vessels with the immune system challenges traditional concepts of brain immune privilege and opens new avenues for understanding and treating neuroinflammatory diseases. The dural venous sinuses function as immunological hubs where circulating T cells sample central nervous system antigens, and the skull-meninges-bone marrow axis provides a localized source of immune cells that can respond rapidly to brain injury without requiring recruitment from the systemic circulation. These discoveries suggest that the meninges are not merely a protective wrapping but an active immunological interface that shapes central nervous system immune responses. In multiple sclerosis, the finding that autoimmune inflammation originates in the leptomeninges rather than the dura has implications for therapeutic targeting, suggesting that interventions aimed at leptomeningeal vessels may be more effective than those targeting the dural vasculature. In Alzheimer's disease, the impairment of meningeal lymphatic drainage and its contribution to amyloid-beta accumulation suggests that restoring lymphatic function could be a disease-modifying strategy.

Fourth, the clinical disorders of meningeal vasculature—epidural hematoma, subdural hematoma, subarachnoid hemorrhage, dural arteriovenous fistula, and spinal cord ischemia—represent a spectrum of pathological processes that share common anatomical substrates but differ in their hemodynamic, inflammatory, and molecular mechanisms. The middle meningeal artery, as the largest dural artery, is central to several of these conditions, serving as the source of bleeding in epidural hematoma, the target for embolization in chronic subdural hematoma and dural arteriovenous fistula, and a collateral pathway in moyamoya disease. Understanding the anatomy, variations, and anastomoses of this artery is essential for safe and effective neurosurgical and endovascular practice. The bridging veins, with their vulnerability to shear forces, are the critical structures in subdural hematoma, and their biomechanical properties may explain why this condition is so common in elderly individuals with brain atrophy. The circle of Willis arteries, as the source of aneurysmal subarachnoid hemorrhage, remain the focus of intensive research into aneurysm formation, rupture risk prediction, and endovascular treatment.

Despite these advances, significant challenges remain in translating meningeal vascular biology into clinical practice. The complexity of meningeal anatomy, with its multiple layers, spaces, and specialized vascular structures, complicates both diagnostic imaging and therapeutic delivery. The heterogeneity of meningeal vessels, which differ not only between layers but also between cranial and spinal regions and even between different cranial locations, makes generalization difficult. Much of our current understanding derives from animal models, and species differences in meningeal vascular anatomy and immune cell composition may limit translational relevance. The development of advanced human imaging techniques, including high-resolution magnetic resonance imaging, computed tomographic angiography, and novel contrast agents, is essential for bridging this gap and enabling non-invasive assessment of meningeal vascular function in health and disease.

Methodological limitations in current research also warrant acknowledgment. The thinness and fragility of meningeal layers make them challenging to study with conventional histological techniques, and the development of whole-mount immunohistochemistry, tissue clearing methods, and three-dimensional spatial transcriptomics has been essential for recent advances. In vivo imaging of meningeal vessels in humans remains limited by spatial resolution and motion artifacts, though dynamic computed tomographic and magnetic resonance angiography are improving. The clinical validation of preclinical findings, particularly regarding meningeal lymphatic function, immune cell trafficking, and collateral remodeling, requires larger prospective studies with standardized methodologies and long-term follow-up.

5. Conclusion

The blood vessels of the meninges have emerged from relative obscurity as a central focus of contemporary neuroscience and vascular biology, revealed as dynamic, multifunctional interfaces essential for central nervous system homeostasis, immune surveillance, waste clearance, and neuroprotection. The arterial supply to the dura mater, dominated by the middle meningeal artery and its extensive anastomotic network, provides a richly perfused environment that supports immunological surveillance and metabolic exchange through fenestrated capillaries. The dural venous sinuses, unique endothelial-lined channels formed by dural reflections, serve as the major drainage routes for cerebral blood and cerebrospinal fluid while functioning as critical immunological hubs for immune cell trafficking. The leptomeningeal vessels, tightly junctioned and integrated into the blood-brain barrier system, maintain the integrity of the cerebrospinal fluid compartments while providing the collateral circulation that can salvage ischemic brain tissue in stroke. The meningeal lymphatic vessels, closely associated with dural arteries and sinuses, provide a drainage pathway for brain waste and antigens that is essential for central nervous system health and whose impairment contributes to neurodegeneration.

Clinically, these advances are reshaping approaches to epidural and subdural hematoma, subarachnoid hemorrhage, dural arteriovenous fistula, and spinal cord ischemia, while opening entirely new therapeutic avenues for stroke, Alzheimer's disease, multiple sclerosis, and other neurological disorders. Middle meningeal artery embolization has transformed the treatment of chronic subdural hematoma and dural arteriovenous fistulas, offering minimally invasive alternatives to open surgery. The recognition of collateral status as a major determinant of stroke outcome has influenced patient selection for endovascular thrombectomy and is guiding the development of collateral enhancement therapies. The meningeal lymphatic system has emerged as a novel target for Alzheimer's disease, with strategies to enhance lymphatic drainage showing promise in preclinical models. Looking forward, the continued application of single-cell genomics, advanced imaging, and microphysiological systems promises to further illuminate the complexity of meningeal vascular biology and to accelerate the translation of mechanistic insights into clinical benefit. As our understanding continues to deepen, the blood vessels of the meninges will increasingly be recognized not merely as conduits for blood, but as active, intelligent interfaces that are indispensable for brain health and promising targets for neurological therapeutics.

References

1. Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337-341. doi:10.1038/nature14432

2. Aspelund A, Antila S, Proulx ST, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. 2015;212(7):991-999. doi:10.1084/jem.20142290

3. Louveau A, Herz J, Alme MN, et al. CNS lymphatic drainage and neuroimmunology: Lessons from learning and memory. Sci Immunol. 2017;2(41):eaal3235. doi:10.1126/sciimmunol.aal3235

4. Da Mesquita S, Louveau A, Vaccari A, et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease. Nature. 2018;560(7717):185-191. doi:10.1038/s41586-018-0368-8

5. Ahn JH, Cho H, Kim JH, et al. Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid. Nature. 2019;572(7767):62-66. doi:10.1038/s41586-019-1419-5

6. Rustenhoven J, Drieu A, Mamuladze T, et al. Functional characterization of the dural sinuses as a neuroimmune interface. Cell. 2021;184(4):1000-1016.e27. doi:10.1016/j.cell.2020.12.040

7. Cugurra A, Mamuladze T, Rustenhoven J, et al. Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and central nervous system. Nat Neurosci. 2021;24(8):1101-1109. doi:10.1038/s41593-021-00896-4

8. Herisson F, Frodermann V, Courties G, et al. Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration. Nat Neurosci. 2018;21(9):1209-1217. doi:10.1038/s41593-018-0214-2

9. Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med. 2012;4(147):147ra111. doi:10.1126/scitranslmed.3003748

10. Engelhardt B, Ransohoff RM. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol. 2012;33(12):579-589. doi:10.1016/j.it.2012.07.004

11. Engelhardt B, Carare RO, Bechmann I, et al. Vascular, glial, and lymphatic immune gateways of the central nervous system. Acta Neuropathol. 2016;132(3):317-338. doi:10.1007/s00401-016-1606-5

12. Weller RO, Sharp MM, Christodoulides M, Carare RO, Mollgard K. The meninges as barriers and facilitators for the movement of fluid, cells and pathogens related to the rodent and human CNS. Acta Neuropathol. 2018;135(3):363-385. doi:10.1007/s00401-018-1807-z

13. Hladky SB, Barrand MA. Fluid and ion transfer across the blood–brain and blood–cerebrospinal fluid barriers; a comparative account of mechanisms and roles. Fluids Barriers CNS. 2016;13(1):19. doi:10.1186/s12987-016-0040-2

14. Brinker T, Stopa E, Morrison J, Klinge P. A new look at cerebrospinal fluid circulation. Fluids Barriers CNS. 2014;11:10. doi:10.1186/2045-8118-11-10

15. Liebeskind DS. Collateral circulation. Stroke. 2003;34(9):2279-2284. doi:10.1161/01.STR.0000086465.41256.3F

16. Faber JE, Zhang H, Macdonald ME, et al. Mechanisms underlying genetic predisposition to cerebral collateral circulation: A focus on the genetic determinants of collateral recruitment and clinical implications. J Cereb Blood Flow Metab. 2022;42(12):2041-2057. doi:10.1177/0271678X221124693

17. Gao F, Lo EH, Dalkara T, Moskowitz MA. Experimental models for the investigation of stroke: from basic mechanisms to clinical translation. J Cereb Blood Flow Metab. 2010;30(3):596-613. doi:10.1038/jcbfm.2009.246

18. McConnell ED, Wei HS, Reitz KM, et al. Cerebral microcirculatory failure after subarachnoid hemorrhage is explained by spreading microvascular constriction and spasms but not by failure of propagation of vascular signals. J Cereb Blood Flow Metab. 2016;36(8):1447-1462. doi:10.1177/0271678X15611956

19. Ducruet AF, Albuquerque FC, Crowley RW, et al. The evolution of endovascular treatment of cranial dural arteriovenous fistula: a single-center experience and literature review. J Neurosurg. 2013;119(1):186-193. doi:10.3171/2013.3.JNS121550